LHC Group (LHCG) Expected to Post Earnings of $0.60 Per Share
Equities analysts expect LHC Group (NASDAQ:LHCG) to announce $0.60 earnings per share for the current quarter, according to Zacks Investment Research. Four analysts have provided estimates for LHC Group’s earnings, with the lowest EPS estimate coming in at $0.57 and the highest estimate coming in at $0.65. LHC Group reported earnings of $0.54 per share during the same quarter last year, which would indicate a positive year over year growth rate of 11.1%. The firm is expected to announce its next quarterly earnings results on Wednesday, November 1st.
On average, analysts expect that LHC Group will report full year earnings of $2.40 per share for the current financial year, with EPS estimates ranging from $2.36 to $2.50. For the next year, analysts expect that the company will report earnings of $2.64 per share, with EPS estimates ranging from $2.60 to $2.75. Zacks Investment Research’s earnings per share calculations are an average based on a survey of research analysts that that provide coverage for LHC Group.
LHC Group (NASDAQ:LHCG) last issued its earnings results on Wednesday, August 2nd. The health services provider reported $0.63 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.09. The company had revenue of $260.20 million during the quarter, compared to the consensus estimate of $254.10 million. LHC Group had a net margin of 4.13% and a return on equity of 9.62%. LHC Group’s quarterly revenue was up 15.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.52 EPS.
A number of research analysts have weighed in on LHCG shares. Benchmark Co. lifted their price objective on shares of LHC Group from $63.00 to $72.00 and gave the company a “buy” rating in a report on Thursday, June 8th. Jefferies Group LLC reaffirmed a “buy” rating and issued a $65.00 price objective on shares of LHC Group in a report on Friday, June 9th. Royal Bank Of Canada reaffirmed a “buy” rating on shares of LHC Group in a report on Tuesday, June 13th. Zacks Investment Research cut shares of LHC Group from a “buy” rating to a “hold” rating in a report on Thursday, July 6th. Finally, BidaskClub cut shares of LHC Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, July 12th. One analyst has rated the stock with a hold rating and ten have issued a buy rating to the stock. LHC Group currently has an average rating of “Buy” and a consensus price target of $66.60.
Shares of LHC Group (LHCG) traded up 1.17% on Friday, reaching $65.57. 419,301 shares of the company traded hands. The company has a 50-day moving average of $63.46 and a 200-day moving average of $59.66. LHC Group has a 1-year low of $32.04 and a 1-year high of $69.35. The stock has a market capitalization of $1.20 billion, a price-to-earnings ratio of 29.01 and a beta of 0.76.
In other news, COO Donald Dwayne Stelly sold 2,650 shares of LHC Group stock in a transaction dated Friday, September 8th. The shares were sold at an average price of $65.34, for a total value of $173,151.00. Following the sale, the chief operating officer now owns 109,235 shares in the company, valued at $7,137,414.90. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 14.80% of the stock is owned by company insiders.
Several hedge funds and other institutional investors have recently made changes to their positions in LHCG. BlackRock Inc. grew its position in shares of LHC Group by 43,223.7% in the first quarter. BlackRock Inc. now owns 1,969,496 shares of the health services provider’s stock valued at $106,157,000 after purchasing an additional 1,964,950 shares during the period. Point72 Asset Management L.P. grew its position in shares of LHC Group by 292.3% in the first quarter. Point72 Asset Management L.P. now owns 439,399 shares of the health services provider’s stock valued at $23,684,000 after purchasing an additional 327,399 shares during the period. FMR LLC grew its position in shares of LHC Group by 14.1% in the first quarter. FMR LLC now owns 1,619,899 shares of the health services provider’s stock valued at $87,312,000 after purchasing an additional 199,849 shares during the period. Royal Bank of Canada grew its position in shares of LHC Group by 50,943.5% in the second quarter. Royal Bank of Canada now owns 165,381 shares of the health services provider’s stock valued at $11,229,000 after purchasing an additional 165,057 shares during the period. Finally, Eagle Asset Management Inc. acquired a new stake in shares of LHC Group in the first quarter valued at about $6,414,000. Institutional investors and hedge funds own 85.93% of the company’s stock.
LHC Group Company Profile
LHC Group, Inc is a holding company. The Company provides post-acute healthcare services to patients through its home nursing agencies, hospice agencies, community-based services agencies and long-term acute care hospitals (LTACHs). The Company operates through four segments: home health services, hospice services, community-based services and facility-based services.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.